Tag Archives: Matthew Bouley

Barclays Keeps a Hold Rating on Cornerstone Building Brands Inc (CNR)

Barclays analyst Matthew Bouley maintained a Hold rating on Cornerstone Building Brands Inc (CNR – Research Report) on August 8 and set a price target of $5. The company’s shares closed on Friday at $4.07, close to its 52-week low

Barclays Believes Skyline Champion Corporation (NYSE: SKY) Won’t Stop Here

In a report issued on August 2, Matthew Bouley from Barclays maintained a Buy rating on Skyline Champion Corporation (SKY – Research Report), with a price target of $34. The company’s shares closed on Friday at $31.10, close to its

Barclays Sticks to Their Buy Rating for Owens Corning (OC)

In a report issued on June 28, Matthew Bouley from Barclays maintained a Buy rating on Owens Corning (OC – Research Report), with a price target of $65. The company’s shares opened today at $58.75. According to TipRanks.com, Bouley is

Analysts’ Opinions Are Mixed on These Conglomerates Stocks: NCI Building (NYSE: NCS) and Adient plc (NYSE: ADNT)

Companies in the Conglomerates sector have received a lot of coverage today as analysts weigh in on NCI Building (NCS – Research Report) and Adient plc (ADNT – Research Report). NCI Building (NCS) In a report issued on May 9,

DR Horton (DHI) Receives a Buy from Barclays

In a report issued on March 15, Matthew Bouley from Barclays maintained a Buy rating on DR Horton (DHI – Research Report), with a price target of $41. The company’s shares opened today at $40.46. Bouley commented: “We had the

Barclays Maintains a Buy Rating on Masco Corp (MAS)

Barclays analyst Matthew Bouley maintained a Buy rating on Masco Corp (MAS – Research Report) on February 8 and set a price target of $39. The company’s shares closed on Friday at $35.90. According to TipRanks.com, Bouley ‘s ranking currently